Medulloblastoma Sensitivity to 17-Allylamino-17-demethoxygeldanamycin Requires MEK/ERK
Christopher Calabrese(St. Jude Children's Research Hospital), Richard J. Gilbertson(University of Cambridge)
Cited by 31
Related Papers
Challenges to curing primary brain tumours
|Nature Reviews Clinical Oncology|2019|965
The NALCN channel regulates metastasis and nonmalignant cell dissemination
|Nature Genetics|2022|76
Natural language processing charts transcriptome evolution to design combination cancer therapies
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1